❌

Normale Ansicht

  • ✇The Guardian
  • Melanoma skin cancer cases in UK hit record level, analysis finds
    Cancer Research UK figures show number diagnosed with most serious form of skin cancer has risen above 20,000 for first timeThe number of cases from the most serious form of skin cancer have reached a record high across the UK, according to analysis by a leading cancer charity.Melanoma cases in the UK have risen above 20,000 for the first time ever, with 20,980 people being diagnosed with the form of cancer in 2022, according to analysis of the latest figures by Cancer Research UK. Continue read
     

Melanoma skin cancer cases in UK hit record level, analysis finds

Cancer Research UK figures show number diagnosed with most serious form of skin cancer has risen above 20,000 for first time

The number of cases from the most serious form of skin cancer have reached a record high across the UK, according to analysis by a leading cancer charity.

Melanoma cases in the UK have risen above 20,000 for the first time ever, with 20,980 people being diagnosed with the form of cancer in 2022, according to analysis of the latest figures by Cancer Research UK.

Continue reading...

© Photograph: Posed by models; Inside Creative House/Getty Images

© Photograph: Posed by models; Inside Creative House/Getty Images

© Photograph: Posed by models; Inside Creative House/Getty Images

  • ✇The Guardian
  • AI to predict how bowel cancer patients will respond to new NHS drug
    PhenMap tool could spare thousands of patients from treatment that would be ineffective for themA new AI-driven way of identifying how patients with advanced bowel cancer will respond to a drug that was recently introduced by the NHS has been announced.Researchers at London’s Institute of Cancer Research and the RCSI University of Medicine and Health Sciences in Dublin have developed the method with the goal of sparing potentially thousands of patients from being given drugs that would be ineffe
     

AI to predict how bowel cancer patients will respond to new NHS drug

13. April 2026 um 10:00

PhenMap tool could spare thousands of patients from treatment that would be ineffective for them

A new AI-driven way of identifying how patients with advanced bowel cancer will respond to a drug that was recently introduced by the NHS has been announced.

Researchers at London’s Institute of Cancer Research and the RCSI University of Medicine and Health Sciences in Dublin have developed the method with the goal of sparing potentially thousands of patients from being given drugs that would be ineffective in fighting their cancers.

Continue reading...

© Photograph: Teodor Lazarev/Alamy

© Photograph: Teodor Lazarev/Alamy

© Photograph: Teodor Lazarev/Alamy

  • ✇The Guardian
  • Repurposed drug may extend survival in aggressive ovarian cancer, trial shows
    Relacorilant, typically used to treat Cushing’s syndrome, could improve outcomes in platinum-resistant casesA drug originally used to treat a rare disease could extend the lives of patients with an aggressive form of ovarian cancer, according to a clinical trial.Platinum-resistant ovarian cancer occurs when the disease progresses within six months of starting platinum-based chemotherapy. This form of chemotherapy is different from other types because it uses compounds that contain platinum to de
     

Repurposed drug may extend survival in aggressive ovarian cancer, trial shows

Relacorilant, typically used to treat Cushing’s syndrome, could improve outcomes in platinum-resistant cases

A drug originally used to treat a rare disease could extend the lives of patients with an aggressive form of ovarian cancer, according to a clinical trial.

Platinum-resistant ovarian cancer occurs when the disease progresses within six months of starting platinum-based chemotherapy. This form of chemotherapy is different from other types because it uses compounds that contain platinum to destroy cancer cells by preventing them from dividing.

Continue reading...

© Photograph: Chinnapong/Shutterstock

© Photograph: Chinnapong/Shutterstock

© Photograph: Chinnapong/Shutterstock

  • ✇The Guardian
  • The Guardian view on cancer survival rates: there is good news about healthcare amid the gloom | Editorial
    Treatments continue to improve. The challenge now facing ministers is hugely unequal outcomesNew analysis from Cancer Research UK, revealing a 29% drop in the rate of people dying from cancer compared with 40 years ago, is a vital counterpoint to grim health headlines about the UK’s outcomes falling behind those of other countries, and the NHS missing its own cancer targets. Prof Chris Whitty, the chief medical officer for England, made a related point in a recent lecture. Stand back from the da
     

The Guardian view on cancer survival rates: there is good news about healthcare amid the gloom | Editorial

09. März 2026 um 19:11

Treatments continue to improve. The challenge now facing ministers is hugely unequal outcomes

New analysis from Cancer Research UK, revealing a 29% drop in the rate of people dying from cancer compared with 40 years ago, is a vital counterpoint to grim health headlines about the UK’s outcomes falling behind those of other countries, and the NHS missing its own cancer targets. Prof Chris Whitty, the chief medical officer for England, made a related point in a recent lecture. Stand back from the day to day, he said, and the extraordinary leaps forward enabled by vaccinations and other advances in treatment and public health come into focus.

This longer view is not a cause for complacency or inaction. England’s latest cancer plan, launched last month, highlighted shocking lapses including lengthy waits for treatment and a failure to tackle inequalities in cancer mortality dating back 15 years. Last year, analysis by the Guardian found that about three-quarters of NHS trusts were failing to reach standards relating to diagnosis and treatment.

Do you have an opinion on the issues raised in this article? If you would like to submit a response of up to 300 words by email to be considered for publication in our letters section, please click here.

Continue reading...

© Photograph: Aaron Chown/PA

© Photograph: Aaron Chown/PA

© Photograph: Aaron Chown/PA

  • ✇The Guardian
  • Quarter of healthy years lost to breast cancer are due to lifestyle factors, research finds
    Largest study of its kind suggests high red meat consumption has biggest impact, followed by smokingMore than a quarter of healthy years lost to breast cancer are due to lifestyle factors such as red meat intake and smoking, according to the largest study of its kind.The study, published in the Lancet Oncology, used data from population-based cancer registries to produce a comprehensive analysis of breast cancer and its risk factors. Continue reading...
     

Quarter of healthy years lost to breast cancer are due to lifestyle factors, research finds

02. März 2026 um 23:30

Largest study of its kind suggests high red meat consumption has biggest impact, followed by smoking

More than a quarter of healthy years lost to breast cancer are due to lifestyle factors such as red meat intake and smoking, according to the largest study of its kind.

The study, published in the Lancet Oncology, used data from population-based cancer registries to produce a comprehensive analysis of breast cancer and its risk factors.

Continue reading...

© Photograph: d3sign/Getty Images

© Photograph: d3sign/Getty Images

© Photograph: d3sign/Getty Images

  • ✇The Guardian
  • AI use in breast cancer screening cuts rate of later diagnosis by 12%, study finds
    Swedish study of 100,000 women found higher rate of early detection, suggesting potential to support radiologistsThe use of artificial intelligence in breast cancer screening reduces the rate of a cancer diagnosis by 12% in subsequent years and leads to a higher rate of early detection, according to the first trial of its kind.Researchers said the study was the largest to date looking at AI use in cancer screening. It involved 100,000 women in Sweden who were part of mammography screening and we
     

AI use in breast cancer screening cuts rate of later diagnosis by 12%, study finds

Swedish study of 100,000 women found higher rate of early detection, suggesting potential to support radiologists

The use of artificial intelligence in breast cancer screening reduces the rate of a cancer diagnosis by 12% in subsequent years and leads to a higher rate of early detection, according to the first trial of its kind.

Researchers said the study was the largest to date looking at AI use in cancer screening. It involved 100,000 women in Sweden who were part of mammography screening and were randomly assigned to either AI-supported screening or to a standard reading by two radiologists between April 2021 and December 2022.

Continue reading...

© Photograph: Eric Gaillard/Reuters

© Photograph: Eric Gaillard/Reuters

© Photograph: Eric Gaillard/Reuters

  • ✇The Guardian
  • Prostate cancer is most commonly diagnosed cancer across UK, study finds
    Cancer charity highlights apparent ‘postcode lottery’ of testing and diagnoses across different regions seen in studyProstate cancer is now the most commonly diagnosed form of cancer across the UK, surpassing breast cancer, according to a leading charity.There were 64,425 diagnoses of prostate cancer in 2022, an analysis of NHS figures by Prostate Cancer UK found, and 61,640 new cases of breast cancer. Continue reading...
     

Prostate cancer is most commonly diagnosed cancer across UK, study finds

Cancer charity highlights apparent ‘postcode lottery’ of testing and diagnoses across different regions seen in study

Prostate cancer is now the most commonly diagnosed form of cancer across the UK, surpassing breast cancer, according to a leading charity.

There were 64,425 diagnoses of prostate cancer in 2022, an analysis of NHS figures by Prostate Cancer UK found, and 61,640 new cases of breast cancer.

Continue reading...

© Photograph: Phanie/Sipa Press/Alamy

© Photograph: Phanie/Sipa Press/Alamy

© Photograph: Phanie/Sipa Press/Alamy

  • ✇The Guardian
  • King Charles hails reduction in cancer treatment as ‘milestone’ in his recovery
    King extols early diagnosis which can give ‘invaluable time’ and backs launch of screening checker toolKing Charles has hailed a “milestone” in his “cancer journey” and revealed he is to reduce his schedule of treatment in the new year, describing the news as a “personal blessing”.His treatment will move into a precautionary phase with its regularity significantly reduced as his recovery reaches a very positive stage, it is understood. His medical team will assess how much longer he will require
     

King Charles hails reduction in cancer treatment as ‘milestone’ in his recovery

12. Dezember 2025 um 20:05

King extols early diagnosis which can give ‘invaluable time’ and backs launch of screening checker tool

King Charles has hailed a “milestone” in his “cancer journey” and revealed he is to reduce his schedule of treatment in the new year, describing the news as a “personal blessing”.

His treatment will move into a precautionary phase with its regularity significantly reduced as his recovery reaches a very positive stage, it is understood. His medical team will assess how much longer he will require treatment to protect and prioritise his continued recovery.

Continue reading...

© Photograph: Tommy Forbes/Bango Studios/Reuters

© Photograph: Tommy Forbes/Bango Studios/Reuters

© Photograph: Tommy Forbes/Bango Studios/Reuters

  • ✇The Guardian
  • The Guardian view on animal testing: we can stop sacrificing millions of lives for our own health | Editorial
    New technologies can reduce our reliance on animal experiments. This isn’t just morally right, it could have scientific and economic benefits tooScience is a slaughterhouse. We rarely acknowledge the degree to which animal life underwrites the research that provides us with medicines, or the regulation that keeps us safe. Live animals were used in 2.64m officially sanctioned scientific procedures in the UK in 2024, many of them distressing or painful and many of them fatal. But the government’s
     

The Guardian view on animal testing: we can stop sacrificing millions of lives for our own health | Editorial

23. November 2025 um 17:30

New technologies can reduce our reliance on animal experiments. This isn’t just morally right, it could have scientific and economic benefits too

Science is a slaughterhouse. We rarely acknowledge the degree to which animal life underwrites the research that provides us with medicines, or the regulation that keeps us safe. Live animals were used in 2.64m officially sanctioned scientific procedures in the UK in 2024, many of them distressing or painful and many of them fatal. But the government’s new strategy to phase out animal testing – published earlier this month – suggests that in the near future emerging technologies can largely replace the use of animals in our scientific endeavours.

The UK previously banned cosmetics testing on animals, and has already taken steps to regulate and reduce their use in research. But some needlessly cruel experiments still take place: the forced swim test (FST) for example, in which a rodent is placed in a body of water it cannot escape and researchers measure whether antidepressants extend the time it struggles for life. The government says no new FST licences will be granted, in effect banning it. Similar targets are set over the next few years to end the testing of caustic chemicals on eyes and skin.

Continue reading...

© Photograph: Robert F Bukaty/AP

© Photograph: Robert F Bukaty/AP

© Photograph: Robert F Bukaty/AP

❌